LMR Partners’s Vor Biopharma VOR Stock Holding History

LMR Partners’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,500	Closed	-$81K	–	1668
2025 Q2	$81K	Buy	+2,500	New	+$22.1K	﹤0.01%	1190

Other funds holding VOR

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACM

Ariose Capital Management Central, Hong Kong, Hong Kong $149M AUM 287.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LMR Partners's VOR Position: Q1 2025 in Review

LMR Partners sold out of Vor Biopharma (VOR) in Q1 2025, closing a stake of 2,556 shares — an estimated $56.7K sold.

LMR Partners first reported a position in VOR in Q1 2022 and held it in 12 quarters. The position peaked at $324K in Q1 2023. 46 funds tracked by Wall St. Rank hold VOR as of Q1 2025.

LMR Partners reported no remaining Vor Biopharma position as of Q1 2025 after selling out during the quarter.
LMR Partners sold 2,556 Vor Biopharma shares in Q1 2025, an estimated $56.7K.
LMR Partners first reported a position in Vor Biopharma in Q1 2022 and held it in 12 quarters.
LMR Partners's Vor Biopharma position peaked at $324K in Q1 2023.
46 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2025.

Based on LMR Partners's 13F filing for Q1 2025, filed 15 May 2025.